Feedback
Candida Species by PCR with Reflex to FKS Drug Resistance by Sequencing
2013784
Ordering Recommendation

Detect and differentiate C. albicans, C. glabrata, C. parapsilosis complex (C. parapsilosis, C. orthopsilosis, C. metapsilosis), C. tropicalis, C. krusei, and C. dubliniensis. If Candida Species by PCR result is detected for a single Candida species (C. albicans, C. glabrataC. krusei, C. parapsilosis complex, C. tropicalis), then Candida FKS Drug Resistance by Sequencing will be added.  

Mnemonic
CAND RFX
Methodology
Qualitative Polymerase Chain Reaction/Sequencing
Performed
Mon, Thu
Reported
7-10 days
New York DOH Approval Status
Specimens from New York clients will be sent out to a New York DOH approved laboratory, if possible.
Submit With Order
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
 
Collect
Body Fluid: Transfer 2 mL body fluid to a sterile container. (Min: 1.5 mL)
Tissue: Transfer to a sterile container and freeze immediately.
Isolate: Transport sealed container with pure isolate on solid media. Place each specimen in an individually sealed bag. 
Specimen Preparation
Body fluid, tissue, or pure isolate of Candida species on solid media. 
Storage/Transport Temperature
Body Fluid and Tissue: Frozen.
Isolate:
Refrigerated. 
Unacceptable Conditions
Plasma, serum, or whole blood. Mixed cultures or isolates other than suspected Candida species. Isolates with no visible colonies. 
Remarks
Specimen source required. 
Stability
Body Fluid: Ambient: 2 weeks; Refrigerated: 2 weeks; Frozen: 2 weeks
Tissue: Ambient: Unacceptable; Refrigerated: Unacceptable; Frozen: 2 weeks
Isolate: Ambient: 1 week; Refrigerated; 2 weeks; Frozen: Unacceptable 
Reference Interval
Test Number
Components
Reference Interval
2013798Candida Species by PCR
2013901Candida FKS Drug Resistance by Sequencing

Interpretive Data
Refer to report.

Compliance Statement B: This test was developed and its performance characteristics determined by ARUP Laboratories. The U.S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.

Note
The Candida Species by PCR detects and differentiates C. albicans, C. glabrata, C. parapsilosis complex (C. parapsilosis, C. orthopsilosis, C. metapsilosis), C. tropicalis, C. krusei, and C. dubliniensis.  If Candida Species by PCR result is detected for a single Candida species (C. albicans, C. glabrata, C. krusei, C. parapsilosis complex, C. tropicalis) then Candida FKS Drug Resistance by Sequencing will be added.  Additional charges apply. If Candida Species by PCR result is not detected, or detected for multiple Candida species, or detected for C. dubliniensis then Candida FKS Drug Resistance by Sequencing will be not be added.
CPT Code(s)
87481; if reflexed, add 87900
Components
Component Test Code*Component Chart NameLOINC
2013785Candida Species Source31208-2
2013786Candida albicans by PCR
2013788Candida glabrata by PCR
2013790Candida parapsilosis complex by PCR
2013792Candida tropicalis by PCR
2013794Candida krusei by PCR
2013796Candida dubliniensis by PCR
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Echinocandin